Abstract:Beta3 -adrenergic (beta3-AR) receptors play a pivotal role in modulating cardiac function, though their precise role in the heart remains controversial. We have recently demonstrated that beta3-mediated cardiac protection via negative inotropy is lost in nNOS-/- animals under pressure overload as compared with WT. However, the exact manner in which beta3-AR activation regulates nNOS signaling to stimulate NOS activity at the cardiomyocyte level is unknown. In this study we used a specific beta3-AR agonist, BRL37344 (BRL), to assess the role of beta3-AR in nNOS regulation in hypertrophied isolated neonatal rat ventricular cardiomyocytes (NRVM). To induce hypertrophy we pretreated cells with norepinephrine for 72 hours, which resulted in a 70% increase in cell size and a 25% increase in beta3-AR mRNA expression as compared with non-hypertrophied cells, analyzed by immunocytochemistry and real-time PCR. In hypertrophied cardiomyocytes, BRL administration lead to a time-dependent 5-fold increase in NOS activity, which was significantly suppressed by nNOS specific inhibitor LVNIO. NOS activity was measured by the arginine-to-citrulline conversion assay. BRL also cause a time-dependent 1.5-fold increase in nNOS phosphorylation at positive regulatory site Ser1416, dephosphorylation of negative regulatory site Ser847, and decreased superoxide generation as compared with unstimulated control. In addition BRL induced phosphorylation eNOS-Ser114, which indicates eNOS deactivation. Pretreatment with pertussis toxin (PTX) suppressed BRL-induced nNOS-Ser1416 phosphorylation, nNOS-Ser847 dephosphorylation, and NOS activity, and unaltered superoxide generation, suggesting Gi/o dependency. Taken together, our data suggest that BRL regulates NOS signaling in ventricular cardiomyocytes via phosphorylation regulation of nNOS. To our knowledge this is first study to demonstrate a role for nNOS phosphorylation as a key factor in beta3-AR signaling. These results contribute significantly to our understanding the negative inotropic properties of myocardial beta3-AR at cellular levels during cardiac sympathetic overstimulation, and will ultimately aid in drug discoveries that target the molecular mechanisms associated heart failure.

Norepinephrine Stimulation Downregulates the Β2‐adrenergic Receptor–nitric Oxide Pathway in Human Pulmonary Artery Endothelial Cells

Norepinephrine Stimulates Mobilization of Endothelial Progenitor Cells after Limb Ischemia

ERK1/2 Pathway-Mediated Norepinephrine Regulates Function of Endothelial Progenitor Cells

ERKl/2 pathway-mediated norepinephrine regulates function of endothelial progenitor cells

Inhibition of Farnesyl Pyrophosphate Synthase Prevents Norepinephrine–induced Fibrotic Responses in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats

Norepinephrine stimulation of alpha1D-adrenoceptor promotes proliferation of pulmonary artery smooth muscle cells via ERK-1/2 signaling.

Endothelial Progenitor Cells May Inhibit Apoptosis of Pulmonary Microvascular Endothelial Cells: New Insights into Cell Therapy for Pulmonary Arterial Hypertension

alpha1A-adrenoceptor is involved in norepinephrine-induced proliferation of pulmonary artery smooth muscle cells via CaMKII signaling.

Berberine Attenuates Pulmonary Arterial Hypertension Via Protein Phosphatase 2a Signaling Pathway Both In Vivo And In Vitro

Norepinephrine Induces Lung Microvascular Endothelial Cell Death by NADPH Oxidase-Dependent Activation of Caspase-3

Abstract 19478: the Protective Effect of Beta3-Adrenergic Signaling Occurs Via Differential Phosphorylation of Nnos in Cardiac Myocytes

Anti-hypertrophic and Anti-Oxidant Effect of Beta3-Adrenergic Stimulation in Myocytes Requires Differential Neuronal NOS Phosphorylation

Endothelial PHD2 deficiency induces nitrative stress via suppression of caveolin-1 in pulmonary hypertension

Abstract 92: the Protective Effect of Β3-Adrenergic Signaling Occurs Via Differential Phosphorylation of Nnos in Cardiac Myocytes

Abstract P215: Β3-Adrenergic Receptor Mediated NOS Signaling in Cardiomyocytes

Norepinephrine Reversibly Regulates the Proliferation and Phenotypic Transformation of Vascular Smooth Muscle Cells

Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone

Abstract 17320: Signaling Mechanisms Involved in Beta3-adrenergic Receptor Regulation of Nnos in Isolated Cardiomyocytes

Influence of noradrenalin on proliferation and phenotype of vascular smooth muscle cells

Therapeutic effect of eNOS-transfected endothelial progenitor cells on hemodynamic pulmonary arterial hypertension